Qiagen Submits Quantiferon-TB Gold Plus for FDA Pre-Market Approval

Qiagen has submitted its application for Quantiferon-TB Gold Plus, which is the fourth generation of the modern blood test for detecting tuberculosis, for pre-market approval by the FDA.

This submission follows the 2016 launch of the device in Europe, the Middle East, Africa, Asia and Latin America. — Cynthia Jessup